CLINICAL_TRIALS ClinicalTrials.gov record update

Phase III Randomized Double-blind Cross-over Trial of Caphosol® Versus NaCl 0.9% in the Relief of Oral Mucositis in Renal Cell Carcinoma, Hepatocellular Carcinoma, and Gastrointestinal Stromal Tumor Patients Receiving Targeted Therapy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01265810
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:45.278319+00:00
Published At: 2017-11-13T00:00:00+00:00
Record Updated At: 2017-11-13
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Oral Complaints", "Renal Cell Carcinoma", "Hepatocellular Carcinoma", "Gastrointestinal Stromal Tumors"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-11-13"
protocolSection.identificationModule.nctId: "NCT01265810"
protocolSection.identificationModule.officialTitle: "Phase III Randomized Double-blind Cross-over Trial of Caphosol\u00ae Versus NaCl 0.9% in the Relief of Oral Mucositis in Renal Cell Carcinoma, Hepatocellular Carcinoma, and Gastrointestinal Stromal Tumor Patients Receiving Targeted Therapy"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.